Latest Headlines

Women in California will now have greater access to safe and comprehensive reproductive health care, thanks in large part to research conducted by the UCSF Bixby Center.

The UCSF Bixby Center’s Safe Motherhood Program is honored to announce that the Non-pneumatic Anti-Shock Garment (NASG/Lifewrap) has been selected as one of UNICEF/USAID/Every Mother Counts/PATH’s Ten Breakthrough Innovations to Save Mother’s Lives in 2015.

The Guttmacher Institute announced Cynthia C. Harper, PhD, Bixby Principal Investigator and Associate Professor in UCSF's Department of Obstetrics, Gynecology and Reproductive Sciences, as the 2013 recipient of the Darroch Award for Excellence in Sexual and Reproductive Health Research.

The UCSF Safe Motherhood Program and Pathfinder International have completed an evaluation of the real-life use of the Life Wrap non-pneumatic anti-shock garment (NASG) in Nigeria.

The UCSF Bixby Center has been selected by the National Institute of Child Health and Human Development (NICHD) as a member of the Contraceptive Clinical Trials Network (CCTN).

Performing routine pelvic exams may be medically unnecessary for healthy women with no symptoms. So why do physicians continue to perform such exams with no clear evidence that they provide preventive benefit?

This is the sixth week of the trial of Dr. Kermit Gosnell, the physician charged with five counts of murder in the deaths of a woman and infants at the Philadelphia abortion clinic he owned and operated.

On April 5th, 2013 a federal district judge ruled that levonorgestrel emergency contraception must be available without a prescription for women of all ages within the next 30 days.

At the American Public Health Association (APHA) annual meeting in October 2012, UCSF Bixby Center researchers shared the first findings from the Turnaway Study.

Instead of seeking to ban abortion outright, which would violate the Supreme Court’s 1973 ruling in Roe v. Wade, anti-abortion groups are pushing laws that would make it too expensive for providers to remain in operation.